Olmesartan MDL Judge: New Jersey Contingency Fee Limits Don’t Apply
CAMDEN, N.J. — The New Jersey federal judge presiding over the olmesartan multidistrict litigation on May 6 dismissed with prejudice a class action seeking to impose New Jersey’s contingency fee limits...To view the full article, register now.
Already a subscriber? Click here to view full article